VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 174 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $335,266 | -2.9% | 50,875 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $345,441 | -8.1% | 50,875 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $375,966 | -28.4% | 50,875 | -4.2% | 0.00% | -25.0% |
| Q3 2022 | $525,000 | -57.0% | 53,110 | -50.8% | 0.00% | -42.9% |
| Q1 2022 | $1,221,000 | -27.9% | 107,985 | 0.0% | 0.01% | -30.0% |
| Q4 2021 | $1,694,000 | -8.5% | 107,985 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $1,851,000 | -20.3% | 107,985 | 0.0% | 0.02% | -15.8% |
| Q2 2021 | $2,323,000 | +43.2% | 107,985 | 0.0% | 0.02% | +35.7% |
| Q1 2021 | $1,622,000 | +101.5% | 107,985 | +76.2% | 0.01% | +100.0% |
| Q4 2020 | $805,000 | +160.5% | 61,300 | +91.6% | 0.01% | +133.3% |
| Q3 2020 | $309,000 | -53.3% | 32,000 | -20.6% | 0.00% | -50.0% |
| Q4 2019 | $661,000 | -29.8% | 40,300 | -43.2% | 0.01% | -33.3% |
| Q3 2019 | $942,000 | – | 70,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |